These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1716007)
21. [Use of beta-blockaders in the treatment of arrhythmias associated with acute myocardial infarct]. Pidrman V; Hamet A Vnitr Lek; 1973 Aug; 19(8):787-93. PubMed ID: 4147214 [No Abstract] [Full Text] [Related]
22. Limitation of infarct size by beta blockers and its potential role for prognosis. Hjalmarson A; Herlitz J Circulation; 1983 Jun; 67(6 Pt 2):I68-71. PubMed ID: 6133646 [TBL] [Abstract][Full Text] [Related]
23. [Secondary prevention after an acute myocardial infarct. Adrenergic beta-blockers, angiotensin-converting enzyme inhibitors and statins for everyone?]. Morais J Rev Port Cardiol; 2000 Jan; 19(1):99-105. PubMed ID: 10731795 [No Abstract] [Full Text] [Related]
24. Rest and the acutely ischaemic heart. Norris RM N Z Med J; 1980 Jul; 92(664):53-6. PubMed ID: 6107887 [TBL] [Abstract][Full Text] [Related]
25. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction]. Halawa B; Mazurek W Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756 [No Abstract] [Full Text] [Related]
26. [Usefulness of beta-blockers in the post-acute myocardial infarct patient]. Shapiro M Arch Inst Cardiol Mex; 1984; 54(2):117-20. PubMed ID: 6204603 [No Abstract] [Full Text] [Related]
27. Limitation of infarct size after acute myocardial infarction. Chatterjee CK J Indian Med Assoc; 1988 Aug; 86(8):221-2. PubMed ID: 2906648 [No Abstract] [Full Text] [Related]
28. [Clinical importance of determining the level of circulating immune complexes in patients in the acute period of myocardial infarct]. Korochkin IM; Chukaeva II; Litvinova SN Kardiologiia; 1985 Feb; 25(2):58-60. PubMed ID: 3990082 [No Abstract] [Full Text] [Related]
29. [Beta blockers after myocardial infarct: patients with low and high risk factors benefit equally]. Ritzmann P Praxis (Bern 1994); 1999 Jun; 88(24):1098. PubMed ID: 10420804 [No Abstract] [Full Text] [Related]
30. [Acute phase proteins in acute myocardial infarct]. Krcmová J; Pidrman V; Fixa B Cas Lek Cesk; 1989 Sep; 128(38):1200-3. PubMed ID: 2478287 [TBL] [Abstract][Full Text] [Related]
31. Clinical aspects of beta-blockade in acute myocardial infarction. Maroko PR; Davidson DM Triangle; 1980; 19(1):19-26. PubMed ID: 6109386 [No Abstract] [Full Text] [Related]
32. [ST elevation in the initial phase of myocardial infarct--a sequela of acute coronary occlusion of an expression of neurohumorally-induced metabolic processes?]. Jentsch G; Kottwitz B Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):347-60. PubMed ID: 2896116 [TBL] [Abstract][Full Text] [Related]
33. Circulating immune complexes in myocardial infarction. Smith GW; McArthur CJ; Simpson IJ J Clin Lab Immunol; 1983 Dec; 12(4):197-9. PubMed ID: 6607358 [TBL] [Abstract][Full Text] [Related]
34. [Beta-receptor blockers after revascularization in coronary sclerosis]. Osterziel KJ Dtsch Med Wochenschr; 1995 Sep; 120(37):1258-9. PubMed ID: 7671786 [No Abstract] [Full Text] [Related]
35. [Use of beta-adrenoblockers in the treatment of acute myocardial infarct patients]. Ol'binskaia LI; Maglakelidze TA; Cherniak MS Klin Med (Mosk); 1987 Feb; 65(2):35-8. PubMed ID: 2883341 [No Abstract] [Full Text] [Related]
36. [Intervention with beta-blockers in acute myocardial infarct]. Verheugt FW Ned Tijdschr Geneeskd; 1990 Jul; 134(29):1392-4. PubMed ID: 1973825 [No Abstract] [Full Text] [Related]
37. [Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct]. De Ambroggi L; Perotta GM; Satolli R; Lotto A Boll Soc Ital Cardiol; 1977; 22(8):1343-51. PubMed ID: 36116 [No Abstract] [Full Text] [Related]
39. Current status of beta adrenergic blockers. Kaul U; Wahi PL Indian J Chest Dis Allied Sci; 1980; 22(1):1-3. PubMed ID: 6111531 [No Abstract] [Full Text] [Related]
40. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue? Baber NS; Lewis JA Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]